Attention Deficit Disorder Medication Response Study

NCT01727414 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

171

Enrollment

OTHER

Sponsor class

Conditions

ADHD - Inattentive Type
ADHD - Combined Type

Interventions

DRUG: OROS-Methylphenidate and placebo for inattentive type pts
DRUG: OROS-Methylphenidate and placebo for combined type pts

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]